|
Pons-Fuster E, Lozano-Caballero O, Martin-Balbuena S, Lucas-Rodenas C, Mancebo-Gonzalez A, De Gorostiza-Frias I, Gonzalez-Ponce CM. Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years. Int J Clin Pharm. 2024 Dec;46(6):1317-1326. doi: 10.1007/s11096-024-01758-2. Epub 2024 Jul 11. PubMed PMID: 38990457.
AÑO: 2024; IF: 3.2
|
38990457
|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea LJ, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Escudero-Bregante JF, Ferri B, Campillo JA, Pons-Fuster E, Martinez Hernandez MD, Martinez-Sanchez MV, Ceballos D, Minguela A. Exploring the Immunoresponse in Bladder Cancer Immunotherapy. Cells. 2024 Nov 22;13(23):1937. doi: 10.3390/cells13231937. PubMed PMID: 39682686; PubMed Central PMCID: PMC11640729.
AÑO: 2024; IF: 5.2
|
|
Garcia Martinez A, Lopez-Jornet P, Pardo Marin L, Pons-Fuster E, Tvarijonaviciute A. Burning Mouth Syndrome Treated with Low-Level Laser and Clonazepam: A Randomized, Single-Blind Clinical Trial. Biomedicines. 2024 May 9;12(5):1048. doi: 10.3390/biomedicines12051048. PubMed PMID: 38791010; PubMed Central PMCID: PMC11118462.
AÑO: 2024; IF: 3.9
|
|
Lopez-Jornet P, Parra-Perez F, Pelaez P, Pons-Fuster E. Retrospective Analysis of Blood Inflammatory Biomarkers in Patients with Oral Lichen Planus: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio. J Clin Med. 2024 Dec 9;13(23):7490. doi: 10.3390/jcm13237490. PubMed PMID: 39685946; PubMed Central PMCID: PMC11641914.
AÑO: 2024; IF: 2.9
|
|
Lopez-Jornet P, Olmo-Monedero A, Peres-Rubio C, Pons-Fuster E, Tvarijonaviciute A. Preliminary Evaluation Salivary Biomarkers in Patients with Oral Potentially Malignant Disorders (OPMD): A Case-Control Study. Cancers (Basel). 2023 Nov 1;15(21):5256. doi: 10.3390/cancers15215256. PubMed PMID: 37958429; PubMed Central PMCID: PMC10650598.
AÑO: 2023; IF: 4.5
|